Instrument: Illumina HiSeq 2500
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: PAIRED
Construction protocol: Myh11-CreERt2/Rosa26-Confetti males received intraperitoneal injections of tamoxifen in corn oil, at 6-8 weeks of age (10 injections of 1 mg/ml each) for lineage labelling. Aortas of healthy male mice were dissected free of fat and connective tissue. To generate single-cell suspensions, endothelial cells were removed manually from dissected aortas using a cotton bud and vessels incubated for 10 minutes in Collagenase Type IV (1 mg/ml, Life Technologies) and porcine pancreatic elastase (1 U/ml, Worthington BioChem) to allow for separation of the adventitia and medial cell layers. Tissue isolated from 5-11 animals was pooled and further digested for 1-2 hours to achieve a single-cell suspension, which was filtered through a 40 μm cell strainer. Individual Sca1-positive (S+) and Sca1-negative (S-) cells expressing a single VSMC-lineage marker (L+) or no VSMC-lineage marker (L-) were FACS-sorted on an Aria-Fusion flow cytometer (BD Bioscience) into separate wells of a 96-well plate. Sca1+ and Sca1- cells were included on the same plate and processed together to generate amplified cDNA using the Smart-seq2 protocol carried out as described previously (Picelli et al, Nature protocols 2014), with the following minor modifications: Primescript (Clontech) was used for reverse transcription, 24 PCR cycles were used for amplification of cDNA, and ERCC control RNA (Invitrogen) was added (1:40,000,000 or 1:80,000,000 dilution in RT-mix). After quality assessment by Bioanalyzer (Agilent) and Quant-iT PicoGreen (Thermo Fisher) quantification, sequencing libraries were prepared from amplified cDNA (approximately 1-6 ng per sample) using the Nextera XT library prep kit (Illumina).